Maandooriyeyaasha Isugeynta Qalabka Isugeynta Qalabka ah ee Kaadi-darrada ah ayaa bixiya Mar-mar, Daaweeyn Hal-Kiniin ah
Qeybinta
Complera waa hal kiniin ah, daroogo isku dhafan oo loo isticmaalo daaweynta HIV, kaas oo ka kooban saddex wakiil oo daaweyn antiretroviral ah :
- Rilpivirine , oo aan aheyn nukleoside-celin-celin-celis-celin-la'aan (NNRTI)
- emtricitabine, nucleotide celinta transcriptase inhibitor (NtRTI)
- Tenofovir disoproxil fumarate (TDF), NtRTI kale
Complera waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka ee Maraykanka (FDA) bishii Agoosto 10, 2011 si loogu isticmaalo dadka waaweyn iyo caruurta da'doodu ka weyn tahay 12 sano kuwaas oo aan waligood ku jirin daaweynta HIV , oo leh fayrus fayrus ah 100,000 unug / m ama , oo miisaamana 77 rodol (35kg) ama ka badan.
Complera waxaa sidoo kale loo isticmaali karaa in lagu badalo daweynta hadda jirta haddii bukaanku uu lahaa fayras aan la ogaan karin oo fayruus ah (
Dejinta
Complera waa kumbuyuutar, qaab kabacsan, oo kiniin ah, oo ka kooban 25mg of rilpivirine, 200mg oo emtricitabine iyo 300mg oo TDF ah. Waxaa ku xeeldheer "GSI" hal dhinac waana mid cad.
Qiyaasta
Hal kiniin maalinle ah oo la qaato cunto. Caymiska waa in aan lagu qaadin dawooyinka kale ee daawada antiretroviral ee loo isticmaalo daaweynta HIV.
Waxyaabaha kale ee saameynaya
Qaar ka mid ah saamaynta daroogada ayaa lagu arkay bukaan-socodka bukaan-socodka bukaan-socodka qaadanaya Complera, oo ah kuwa ugu badan:
- Lalabbo
- Madax xanuun
- Insomnia
- Murugo
Dhibaatooyinka kale ayaa caadi ahaan soo noqnoqonaya, iyada oo tiro yar oo bukaanno ah ay joojinayaan sababtoo ah daaweynta xasaasiyadda.
Khilaafaadka
Bixiyaha waa in aan lagu qaadin daawooyinka soo socda ama dheeraadka ah:
- Daawada ka hortagga uur-qaadida: Tegretol, Trilepta, phenobarbital, phenytoin
- Daawada ka hortagga qaaxada: Mycobutin, Rifater, Rifamate, Rimactane, Rifadin, Priftin
- Noocyada Badeecada Proton (PPIs): Nexium, Kapidex, Dexilant, Prevacid, Losec, Prilosec, Protonix, Aciphex ama wax kasta ee PPI
- Daawada steroid: dexamethasasone (inkastoo ay dhici karto in la qaato qiyaasta hal mar haddii caafimaad ahaan la tilmaamay)
- St. John Wort
Had iyo jeer la socodsii dhakhtarkaaga daroogo kasta ama kudheer, ama laguu qoro, oo laga yaabo inaad qaadato ka hor intaadan bilaabin daaweyn antiretroviral ah.
Tixgelinno Kale
Bixiyaha laguma talinayo bukaanka qaba naafanimada kelyaha (oo lagu qeexay inay tahay in lagu qiyaaso nadiifinta wax soo saarka ee wax ka yar 30mL daqiiqaddii). Fadlan kugula tali dhakhtarkaaga haddii laguu daaweeyay ama lagu daaweynayo kalyo kasta ee dhakhtarka kale.
Complera laguma talinayo bukaanka qaba cilladda beerka ama kuwa qaba infakshanka cagaarshow B (HBV) ee daba-dheer sababta oo ah waxay si weyn u sii xumeyn kartaa dhibaatooyinka beerka. Waxaa lagula talinayaa in dadka qaba HIV laga baaro HBV ka hor inta aysan qorin Complera. Fadlan kugula tali dhakhtarkaaga haddii aad qabto dhibaatooyinka beerka iyo / ama taariikhda cagaarshow.
Qaybta rilpivirine ee Complera waxay sababi kartaa dareen-celin culus oo ah tiro yar oo bukaano ah, badanaaba qaabka finanka, indhaha indhaha ("pink eye"), bararka wajiga, qandhada, ama jawaab-celin kale oo xasaasiyad ah. Caadi ahaan, dareen-celinta dareen-celinta waxay joogtaa 1-6 usbuuc kaddib marka la bilaabayo daweynta. U sheeg dhakhtarkaaga isla markiiba calaamadahaan oo kale. Xaaladaha daran, daaweynta ayaa u badan inay u baahan tahay in la joojiyo.
Cusboonaysiinta Daaweynta
Qorshaha cusub ee Complera waxaa ansixiyay FDA on March 1, 2016, oo lagu suuq-gareeyay magaca Odefsey . Nidaamkan cusubi wuxuu bedelayaa qaybta TDF ee daroogada loo yaqaan 'tenofovir alafenamide' (TAF), kan dambe oo loo yaqaan 'pro-drug'.
Si ka duwan TDF, TAF ma leh daroogo firfircoon, laakiin waxay isticmaashaa dheef-shiid kiimikaadeeda si loogu badalo qaabkeeda firfircoon. Sidaa daraadeed, daroogada ayaa si wax ku ool ah u siisa unugyada qiyaasaha hooseeya, iyo sidoo kale sunta daroogada oo aad u hooseeya (gaar ahaan marka la eego kelyaha daciifinta ee la xidhiidha isticmaalka TDF).
Ilaha:
Maamulka Cuntada iyo Maandooriyeyaasha Mareykanka (FDA_. "Oggolaanshaha Complera: emtricitabine / rilpivirine / tenofovir DF isku dhafan oo go'an." Silver Srping, Maryland, oo la soo saarey Agoosto 10, 2011.
Gilead Sciences. "Compilera - Warbixinaha Wargelinta". Foster City, California; heley March 18, 2016.
Reuters. "BRIEF - Gilead Sciences ayaa sheegaysa in FDA ay ogolaatay Odefsey" Bixitaankii Maarso 1, 2015.